![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Positron Receives Final Installment From Sales of Notes to IMAGIN
Positron Receives Final Installment From Sales of Notes to IMAGIN
March 21, 2005
Positron, a manufacturer of positron emission tomography (PET) scanners, announced that it had received the final installment of funds from sale of $2 million worth of 10 percent convertible promissory notes to IMAGIN Diagnostic Centres, a private Canadian company engaged in the development of PET centers. Proceeds from the notes were used to build a sales and marketing team and support past and current working capital needs.
Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050321005272&newsLang=en)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct